High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies
Status:
Completed
Trial end date:
2001-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Deoxycytidine may protect patients from the side effects of
high-dose cytarabine.
PURPOSE: Phase I trial to study the effectiveness of high-dose cytarabine given with
deoxycytidine in treating patients who have refractory acute myelogenous leukemia or other
lymphoma or leukemia.